Status:
COMPLETED
Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors
Lead Sponsor:
Amgen
Conditions:
Tumors
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This study will determine the safety and pharmacokinetics of AMG 706 in subjects with advanced solid tumors.
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00093873
Start Date
July 1 2003
End Date
December 1 2006
Last Update
May 15 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.